Get started
Work

Supplementary Table S3 from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Year: 2023
Type: supplementary-materials
Abstract: Individual details of baseline patient characteristics
DOI: 10.1158/2767-9764.24018706.v1
Authors: Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4386096395
Cites:
Cited by:
Related to: 10